Abstract
The current use of metrics-driven approaches to improve the productivity of pharmaceutical drug discovery will fail. This article presents an approach to the use of performance metrics that has the potential to guide fundamental industry improvement though cooperation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Grabowski, H., Vernon, J. & Di Masi, J. A. Returns on research and development for 1990s new drug introductions. Pharamcogenomics 20, S11–S29 (2002).
DiMasi, J. A. The value of improving the productivity of the drug development process: faster times and better decisions. Pharmacoeconomics 20, S1–S10 (2002).
Sim, P. & Gill, J. Results of the 2002 Drug Discovery Performance Metrics Survey (CMR International, Epsom, UK, 2003).
CHI Strategies to Optimize R&D Performance, June 9–19, Philadelphia, Pennsylvania, USA (2003).
Phacilitate, Inc. R&D Leaders Forum. October, Geneva, Switzerland (2003).
IBC Drug Discovery Technology Conference, August 10–15, Boston, Massachusetts, USA (2003).
Parexel's Pharmaceutical R&D Statistical Sourcebook 2002/2003 (Parexel International, Waltham, USA, 2003).
A Revolution in R&D: How Genomics and Genetics are Transforming the Biopharmaceutical Industry (Boston Consulting Group, Boston, USA 2001).
Pharma 2010: The Threshold of Innovation (IBM Business Consulting Services, Armonk, USA, 2002).
Acknowledgements
The author gratefully acknowledges the valuable input of Drs Benjamin Bowen and Dominic Spinella, as well as other former colleagues at Acumen Sciences. Many of the ideas presented were developed while the author was Vice President of Research at Acumen Sciences, LLC.
Author information
Authors and Affiliations
Related links
Related links
FURTHER INFORMATION
Cambridge HealthTech Institute
Cambridge Healthtech Institute
Rights and permissions
About this article
Cite this article
Cohen, C. A path to improved pharmaceutical productivity. Nat Rev Drug Discov 2, 751–753 (2003). https://doi.org/10.1038/nrd1180
Issue Date:
DOI: https://doi.org/10.1038/nrd1180
This article is cited by
-
The Role of Molecular Imaging in Drug Discovery and Development
Clinical Pharmacology & Therapeutics (2008)
-
A role for fMRI in optimizing CNS drug development
Nature Reviews Drug Discovery (2006)
